WVE - Wave Life Sciences Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
17,203
14,414
3,704
1,485
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
166,112
134,428
79,309
40,818
Selling General and Administrative
47,818
39,509
26,975
15,994
Total Operating Expenses
213,930
173,937
106,284
56,812
Operating Income or Loss
-196,727
-159,523
-102,580
-55,327
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
21,838
12,917
1,247
205
Income Before Tax
-174,858
-146,584
-101,327
-54,785
Income Tax Expense
-103
69
708
616
Income from Continuing Operations
-174,755
-146,653
-102,035
-55,401
Net Income
-174,755
-146,653
-102,035
-55,401
Net Income available to common shareholders
-174,755
-146,653
-102,035
-55,401
Reported EPS
Basic
-
-5.06
-3.85
-2.43
Diluted
-
-5.06
-3.85
-2.43
Weighted average shares outstanding
Basic
-
28,970
26,513
22,801
Diluted
-
28,970
26,513
22,801
EBITDA
-
-153,942
-100,425
-55,327